Form 4 for CAPR CAPRICOR THERAPEUTICS, INC.
Accepted 2024-04-24 00:00:00 ET · period of report 2024-04-23 · accession 0001415889-24-011416 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-04-24 | 2024-04-23 | CAPR | Musket David B | Dir | M - OptEx | $1.39 | +16.2K | 47.7K | +51% | +$22.5K |
| DM | 2024-04-24 | 2024-04-23 | CAPR | Musket David B | Dir | M - OptEx | $0.00 | -16.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-23 | M | A | 16,156 | $1.39 | 47,692 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-04-23 | M | D | 2,750 | $0.00 | 0 | D | $1.39 · — to 2027-01-03 | 2,750 Common Stock | (F3) This option was granted on January 3, 2017 and was previously reported as covering 27,500 shares at an exercise price of $2.55 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020. (F4) The shares vested 1/12th of the first day of each month, commencing February 1, 2017 with the last 1/12th vesting on December 31, 2017. |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-04-23 | M | D | 856 | $0.00 | 0 | D | $1.39 · — to 2027-01-03 | 856 Common Stock | (F1) This option was granted on January 3, 2017 and was previously reported as covering 8,560 shares at an exercise price of $2.55 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020. (F2) The shares vested 1/48th of the first day of each month, commencing February 1, 2017. |
| 4 | Derivative | Stock Option (Right to Buy) | 2024-04-23 | M | D | 5,750 | $0.00 | 0 | D | $1.39 · — to 2029-08-08 | 5,750 Common Stock | (F9) This option was granted on August 8, 2019 and was previously reported with an exercise price of $3.25 per share, but was adjusted to reflect a share reprice to $1.39 per share that occurred on February 12, 2020. (F10) The shares vested 1/48th of the first day of each month, commencing September 1, 2019. |
| 5 | Derivative | Stock Option (Right to Buy) | 2024-04-23 | M | D | 2,750 | $0.00 | 0 | D | $1.39 · — to 2028-01-02 | 2,750 Common Stock | (F7) This option was granted on January 2, 2018 and was previously reported as covering 27,500 shares at an exercise price of $1.57 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020. (F8) The shares vested 1/12th of the first day of each month, commencing February 1, 2018 with the last 1/12th vesting on December 31, 2018. |
| 6 | Derivative | Stock Option (Right to Buy) | 2024-04-23 | M | D | 3,000 | $0.00 | 0 | D | $1.39 · 2019-08-08 to 2029-08-08 | 3,000 Common Stock | (F9) This option was granted on August 8, 2019 and was previously reported with an exercise price of $3.25 per share, but was adjusted to reflect a share reprice to $1.39 per share that occurred on February 12, 2020. |
| 7 | Derivative | Stock Option (Right to Buy) | 2024-04-23 | M | D | 1,050 | $0.00 | 0 | D | $1.39 · — to 2028-01-02 | 1,050 Common Stock | (F5) This option was granted on January 2, 2018 and was previously reported as covering 10,500 shares at an exercise price of $1.57 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020. (F6) The shares vested 1/48th of the first day of each month, commencing February 1, 2018. |